ISRG · News · 20260817N

Competition and Market Share

INTUITIVE SURGICAL INC · 2026-08-17 · Importance 47 · Surprise 60

The FDA cleared Johnson & Johnson’s Ottava robotic surgical system, introducing a significant competitor to Intuitive Surgical in soft-tissue surgery. The competitive impact will depend on U.S. da Vinci procedure growth and how quickly Ottava gains market share. Third-party reporting identified the new entrant as a key factor behind investor concerns about Intuitive’s future performance. Management’s decision not to raise full-year guidance after the second quarter was also cited as contributing to the negative market reaction.

Key facts